Skip to content

Corvel CRVL Stock-Based Comp

Stock-Based Comp at other companies

CVS Health logo
CVS HealthCVS
ExlService Holdings logo
ExlService HoldingsEXLS
SS&C Technologies logo
SS&C TechnologiesSSNC
Medline, Inc.
 logo
Medline, Inc. MDLN
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$248.5M+7.4%
Gross profit$63.0M+8.3%
Net income$31.0M+17.4%
EPS (diluted)$0.61+19.6%

Balance sheet

See full
Cash & equivalents$233.1M+36.6%
Total debt$28.1M+0.1%
Total equity$394.2M+22.4%
Total assets$643.0M+17.8%

Cash flow

See full
Operating cash flow$29.5M+28.6%
CapEx$9.2M+5.9%
Free cash flow$20.3M+42.3%

Valuation

See full
Market cap$3.03B-51.4%
Enterprise value$2.82B-53.8%
P/E27.4×-38.0×
P/S3.2×-3.8×

Profitability

See full
Gross margin24.3%+0.9pp
Net margin11.5%+0.9pp
FCF margin11.5%+1.3pp

Returns & leverage

See full
Return on equity30.8%-2.6pp
Debt / equity0.1×0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Corvel’s 10-K, filed May 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvel's stock-based comp?
Corvel (CRVL) reported stock-based comp of $1.23M in Q1 2026.
How has Corvel's stock-based comp changed year-over-year?
Corvel's stock-based comp decreased by 7.8% year-over-year, from $1.34M to $1.23M.
What is the long-term trend for Corvel's stock-based comp?
Over 4 years (2022 to 2026), Corvel's stock-based comp has grown at a 1.0% compound annual growth rate (CAGR), from $5.2M to $5.41M.